The global OTC healthcare sector was valued at $169.2 billion in 2022 and is expected to yield a CAGR of 2.4% during 2022-27, to reach $190.6 billion in 2027. Asia-Pacific was the largest market in the global OTC healthcare sector in 2022, with value sales of $62.6 billion. The region is also expected to be the fastest-growing region for the OTC healthcare sector, with a value CAGR of 3.2% during 2022-27, followed by the Americas with 2.6%. The global OTC healthcare sector remained fragmented in 2022, with the top five companies accounting for a value share of 19.5%, led by GSK Plc with a value share of 6.2%.
This report brings together multiple data sources to provide a comprehensive overview of the global OTC healthcare sector. It includes an analysis on the following:
Sector overview: Provides an overview of current sector scenarios in terms of ingredients, manufacturer claims, and labeling. The analysis also provides a regional overview across five regions-Asia-Pacific, Middle East & Africa, the Americas, Western Europe, and Eastern Europe-highlighting sector size, growth drivers, latest developments, and future challenges for each region. This data includes off-trade data only.
High-potential countries: Provides risk-reward analysis of the top four high-potential countries in each region based on market assessment, economic development, governance indicators, socio-demographic factors, and technological infrastructure.
Country and regional analysis: Provides a deep-dive analysis of 10 high-potential countries covering value growth during 2022-27, key challenges, consumer demographics, and key trends. Market size, company and brand analysis, and distribution analysis includes off-trade data.
Competitive landscape: Provides an overview of leading brands at a global and regional level, as well as analyzing the product profile, country-level presence, market share, and growth of private labels in each region.
Key distribution channels: Provides analysis of the leading distribution channels in the global OTC healthcare sector in 2022. It covers cash & carries & warehouse clubs, convenience stores, e-retailers, other specialist retailers, parapharmacies/drugstores, chemists/pharmacies, direct sellers, food & drinks specialists, hypermarkets & supermarkets, and others.
Select industry metrics: Provides data for alternative content including patent analytics, job analytics, and deals analytics.
The report provides a detailed analysis of the countries in the region, covering the key challenges, competitive landscape and demographic analysis, that can help companies gain insight into the country specific nuances
The analysts have also placed a significant emphasis on the key trends that drive consumer choice and the future opportunities that can be explored in the region, than can help companies in revenue expansion
To gain competitive intelligence about leading brands in the industry in the region with information about their market share and growth rates
This report brings together multiple data sources to provide a comprehensive overview of the global OTC healthcare sector. It includes an analysis on the following:
Sector overview: Provides an overview of current sector scenarios in terms of ingredients, manufacturer claims, and labeling. The analysis also provides a regional overview across five regions-Asia-Pacific, Middle East & Africa, the Americas, Western Europe, and Eastern Europe-highlighting sector size, growth drivers, latest developments, and future challenges for each region. This data includes off-trade data only.
High-potential countries: Provides risk-reward analysis of the top four high-potential countries in each region based on market assessment, economic development, governance indicators, socio-demographic factors, and technological infrastructure.
Country and regional analysis: Provides a deep-dive analysis of 10 high-potential countries covering value growth during 2022-27, key challenges, consumer demographics, and key trends. Market size, company and brand analysis, and distribution analysis includes off-trade data.
Competitive landscape: Provides an overview of leading brands at a global and regional level, as well as analyzing the product profile, country-level presence, market share, and growth of private labels in each region.
Key distribution channels: Provides analysis of the leading distribution channels in the global OTC healthcare sector in 2022. It covers cash & carries & warehouse clubs, convenience stores, e-retailers, other specialist retailers, parapharmacies/drugstores, chemists/pharmacies, direct sellers, food & drinks specialists, hypermarkets & supermarkets, and others.
Select industry metrics: Provides data for alternative content including patent analytics, job analytics, and deals analytics.
Key Highlights
Manufacturing and retailers seek latest information on how the market is evolving to formulate their sales and marketing strategies. There is also demand for authentic market data with a high level of detail. This report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities of growth within the industry in the regionThe report provides a detailed analysis of the countries in the region, covering the key challenges, competitive landscape and demographic analysis, that can help companies gain insight into the country specific nuances
The analysts have also placed a significant emphasis on the key trends that drive consumer choice and the future opportunities that can be explored in the region, than can help companies in revenue expansion
To gain competitive intelligence about leading brands in the industry in the region with information about their market share and growth rates
Scope
- This report provides an overview of the current OTC healthcare scenario regarding the future outlook in terms of sector overview, high-potential countries, country and regional analysis, competitive landscape, distribution, and industry metrics. The analysis also covers regional overview across five regions - Asia-Pacific, Middle East & Africa, Americas, Western Europe, and Eastern Europe - highlighting industry size, growth drivers, latest developments, and future inhibitors for the regions
Reasons to Buy
- Manufacturing and retailers seek latest information on how the market is evolving to formulate their sales and marketing strategies. There is also demand for authentic market data with a high level of detail. This report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities of growth within the sector in the region
- The report provides a detailed analysis of the countries in the region, covering the key challenges, competitive landscape and demographic analysis, that can help companies gain insight into the country specific nuances
- The analysts have also placed a significant emphasis on the key trends that drive consumer choice and the future opportunities that can be explored in the region, than can help companies in revenue expansion
- To gain competitive intelligence about leading brands in the sector in the region with information about their market share and growth rates
Table of Contents
- Executive Summary
Part 1: Sector Overview
Part 2: Identifying High-Potential Countries
Part 3: Country Deep-Dive Analysis
Part 4: Competitive Environment
Part 6: Market Share of Private Labels
Part 7: Key Distribution Channels
Part 8: Select Industry Metrics
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GSK Plc
- Johnson & Johnson Services Inc.
- Bayer AG
- Sanofi-Aventis Groupe
- Reckitt Benckiser Group Plc
- Nu Skin Enterprises Inc.
- Herbalife International Inc.
- Abbott Laboratories